We are live on ! Find out more
ETRM

EnteroMedics
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

49 hedge funds and large institutions have $19.8M invested in EnteroMedics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $667K | Put options by funds: $192K

39% more capital inflows, than outflows

Capital inflows: $4.12M | Capital outflows: $2.95M

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

1.37% more ownership

Funds ownership: 21.9% → 23.27% (+1.4%)

13% less funds holding

Funds holding: 56 → 49 (-7)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
49
Holders Change
-7
Holders Change %
-12.5%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
12
Closed
12
Calls
$667​K
Puts
$192​K
Net Calls
+$475​K
Net Calls Change
-⁠$928​K

ETRM Hedge Fund Activity: Q3 2014 in Review

49 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics (ETRM) for Q3 2014, worth a combined $19.8M — down 16% from $23.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ETRM and 5 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 15 added.

The largest buyer was Iguana Healthcare Management, adding an estimated $2.43M. The largest seller was Royce & Associates, cutting an estimated $575K.

  • 49 institutional investors held EnteroMedics (ETRM) as of Q3 2014, down from 56 in Q2 2014.
  • Funds reported $19.8M of EnteroMedics stock for Q3 2014, down 16% quarter-over-quarter.
  • 5 funds opened new EnteroMedics positions in Q3 2014 and 12 closed out, a net change of -7 holders.
  • The largest EnteroMedics buyer in Q3 2014 was Iguana Healthcare Management, an estimated $2.43M added.
  • The largest EnteroMedics seller in Q3 2014 was Royce & Associates, an estimated $575K sold.

Based on aggregated 13F filings for Q3 2014.